Monday, July 25, 2011

Cord Blood and Hearing Loss - First Clinical Trial Underway

The first ever clinical trial reviewing the use of umbilical cord blood to treat acquired hearing loss in infants is currently underway. Acquired sensorineural hearing loss is not present at birth and usually develops due to infection, head trauma, or loud noises. Babies with hearing loss have a particularly hard time learning language and tend to struggle in educational settings as they grow older. Six out of every thousand children will develop acquired hearing loss.

Several studies have found that using stem cells to help regenerate parts of the inner ear to be largely successful. However, this study is the first of its kind to use a child’s own cord blood to treat their hearing loss. There are currently no known treatments for hearing loss.

Only children six weeks to 18 months of age with cord blood banked at Cord Blood Registry are eligible to take part in the study. The hearing loss must be acquired and cannot be genetic. Only ten children will be able to take part. For more information and to register for the clinical trial, click here.

Do you have a child with hearing loss?

Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children [NIH]
Sensorineural Hearing Loss [ASHA]
Can Stem Cells Cure Deafness? [Hearing Loss Web]
Cord Blood Clinical Trials Overview [CBR]